Is this you? Create Your Porfile
Avatar

Peter Habenberger

Bayer HealthCare Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Peter Habenberger is active.

Explore More

Publication

Featured researches published by Peter Habenberger.

Archive | 2004

Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases

Axel Choidas; Alexander Backes; Matthew Cotten; Ola Engkvist; Beatrice Felber; Achim Freisleben; Klaus Godl; Zoltán Greff; Peter Habenberger; Doris Hafenbradl; Christian Hartung; Thomas Herget; Edmund Hoppe; Bert Klebl; Andrea Missio; Gerhard Müller; Wilfried Schwab; Birgit Zech; Jose Bravo; John Harris; Joelle Le; Jackie Macritchie; Vladimir Savic; Brad Sherborne; Don Simpson

Archive | 2002

Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases

János Pató; Gyorgy Keri; Laszlo Orfi; Frigyes Wáczek; Zoltán Horváth; Péter Bánhegyi; István Szabadkai; Jenö Marosfalvi; Zsolt Székelyhidi; Zoltán Greff; Axel Choidas; Gerald Bacher; Henrik Daub; Sabine Obert; Alexander Kurtenbach; Peter Habenberger

Archive | 2012

CDK9 INHIBITORS IN THE TREATMENT OF MIDLINE CARCINOMA

Axel Choidas; Bert Klebl; Peter Habenberger; Jan Eickhoff; Roman K. Thomas; Johannes M. Heuckmann

Archive | 2012

SUSCEPTIBILITY TO SELECTIVE CDK9 INHIBITORS

Axel Choidas; Bert Klebl; Peter Habenberger; Jan Eickhoff; Roman K. Thomas; Johannes M. Heuckmann

Archive | 2012

Empfindlichkeit gegen selektive cdk9-inhibitoren

Axel Choidas; Bert Klebl; Peter Habenberger; Jan Eickhoff; Roman K. Thomas; Johannes M. Heuckmann

Archive | 2012

Cdk9-hemmer bei der behandlung eines mittellinienkarzinoms

Axel Choidas; Bert Klebl; Peter Habenberger; Jan Eickhoff; Roman K. Thomas; Johannes M. Heuckmann

Archive | 2012

Inhibiteurs de cdk9 pour traiter le carcinome de la ligne médiane

Axel Choidas; Bert Klebl; Peter Habenberger; Jan Eickhoff; Roman K. Thomas; Johannes M. Heuckmann

Archive | 2011

CDK9-Hemmer zur Behandlung eines Mittellinienkarzinoms

Axel Choidas; Bert Klebl; Peter Habenberger; Jan Eickhoff; Roman K. Thomas; Johannes M. Heuckmann

Archive | 2011

Empfindlichkeit auf selektive CDK9-Inhibitoren

Axel Choidas; Bert Klebl; Peter Habenberger; Jan Eickhoff; Roman K. Thomas; Johannes M. Heuckmann

Archive | 2004

Pharmazeutisch wirksame 4,6-disubstituierte aminopyrimidinderivate als modulatoren von proteinkinasen

Axel Choidas; Alexander Backes; Matt Cotten; Ola Engkvist; Beatrice Felber; Achim Freisleben; Klaus Godl; Zoltán Greff; Peter Habenberger; Doris Hafenbradl; Christian Hartung; Thomas Herget; Edmund Hoppe; Bert Klebl; Andrea Missio; Gerhard Müller; Wilfried Schwab; Birgit Zech; Jose Bravo; John Harris; Joelle Le; Jackie Macritchie; Vladimir Savic; Brad Sherborne; Don Simpson

Explore More

Collaboration

Dive into the Peter Habenberger's collaboration.

Top Co-Authors
Avatar

Axel Choidas

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Bert Klebl

University of Erlangen-Nuremberg

View shared research outputs
Top Co-Authors
Avatar

Jan Eickhoff

GPC Biotech

View shared research outputs
Top Co-Authors
Avatar

Johannes M. Heuckmann

Max Planck Society

View shared research outputs
Top Co-Authors
Avatar

Roman K. Thomas

University of Cologne

View shared research outputs
Top Co-Authors
Avatar

Zoltán Greff

École Polytechnique Fédérale de Lausanne

View shared research outputs
Top Co-Authors
Avatar

Brad Sherborne

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Don Simpson

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Jackie Macritchie

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

John Harris

Bayer HealthCare Pharmaceuticals

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge